NCT05844111View on ClinicalTrials.gov

A Study to Investigate the Absorption, Metabolism and Excretion of [14C]-BGB-11417

PHASE1CompletedINTERVENTIONAL

Enrollment

6

Participants

Timeline

Start Date

May 22, 2023

Primary Completion Date

June 18, 2023

Study Completion Date

June 18, 2023

Conditions

Healthy Volunteers

Interventions

DRUG

[14C]-BGB-11417

A single oral dose of liquid formulation

Trial Locations (1)

78744-1645

Ppd Development, Lp, Austin

Sponsors

Lead Sponsor

All Listed Sponsors

lead

BeiGene

INDUSTRY